Anticoronavirals: the development of COVID-19 therapies and the challenges that remain

United Kingdom News News

Anticoronavirals: the development of COVID-19 therapies and the challenges that remain
United Kingdom Latest News,United Kingdom Headlines
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 53 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 71%

Anticoronavirals: the development of COVID-19 therapies and the challenges that remain NatureMicrobiol pfizer COVID19 coronavirus covid antivirals therapies

By Neha MathurMay 8 2023Reviewed by Danielle Ellis, B.Sc. In a recent article published in Nature Microbiology, researchers highlighted the pace of development of coronavirus disease 2019 therapies during the pandemic and the challenges that hinder the widespread availability of anticoronavirals.

Clinical trials have established that mAbs and antivirals effectively combat COVID-19 when administered up to 10 days after symptom onset and within three to five days following the onset of symptoms, respectively. COVID-19 patients in stage 2 develop viral pneumonia, cough and fever, lung inflammation causing shortness of breath, and lung aberrations, such as ground glass opacities.

The NIH rejected giving vitamin/mineral supplements, e.g., zinc, for hospitalized COVID-19 patients. On the contrary, they recommended prompt use of supplemental oxygenation and high-flow nasal cannula in patients with ARDS. In the absence of effective treatments, clinical recommendations by NIH continue to change and evolve.

Another randomized phase III trial evaluated ivermectin, metformin, and fluvoxamine, all repurposed drug candidates, for early COVID-19 treatment of overweight or obese adults. Earlier pivotal efficacy and clinical studies found that molnupiravir provided no clinical benefit in hospitalized COVID-19 patients.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

The safety and efficacy of FINLAY-FR-2/1A, a new protein-based COVID-19 vaccineThe safety and efficacy of FINLAY-FR-2/1A, a new protein-based COVID-19 vaccineThe safety and efficacy of FINLAY-FR-2/1A, a new protein-based COVID-19 vaccine FINLAYFR2 Soberana02 FINLAYFR1A SoberanaPlus COVID19 Phase3trial clinicaltrial vaccination immunization publichealth pandemic JAMANetworkOpen
Read more »

Covid hotspot with 250% increase as infectious Arcturus variant spreadsCovid hotspot with 250% increase as infectious Arcturus variant spreadsDespite the increase for some areas, there are more Lancashire areas with no recorded data at all
Read more »

DNA inherited from Neanderthals may impact human nose shape, study findsDNA inherited from Neanderthals may impact human nose shape, study findsResearchers from University College London (UCL) say the gene may have come from natural selection as ancient humans adapted from colder climates after leaving Africa.
Read more »

As Global Health Emergency Ends, Mass. Hospitals Set to Lift Masking RequirementsAs Global Health Emergency Ends, Mass. Hospitals Set to Lift Masking RequirementsThe World Health Organization made headlines Friday, announcing that COVID-19 is no longer a global health emergency. The emergency had been in effect for over three years. “COVID is absolutely still a threat,” said Dr. Robert Klugman of UMass Memorial Medical Center. “Every day, every way, unfortunately.” The official public health emergency will be lifted on Thursday in the United…
Read more »

ITV Responds To Speculation Surrounding Carol McGiffin's Loose Women ExitITV Responds To Speculation Surrounding Carol McGiffin's Loose Women ExitCarol made headlines last week when she said she felt she “had to step away from” Loose Women due to an apparent contract issue.
Read more »



Render Time: 2025-02-19 19:13:27